A van Gossum - JoVE Visualize

Showing results (91-100 of 127) with videos related to

Pageof 13

Sort By:

Clinical Nutrition (Edinburgh, Scotland)|April 1, 1996

Home parenteral nutrition in adults: a multicentre survey in Europe in 1993, A Van Gossum, H Bakker, et al.

Gut|June 15, 2004

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisD Franchimont, S Vermeire, H El Housni, et al.

Scandinavian Journal of Gastroenterology|August 23, 2002

A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphismE Louis, S Vermeire, P Rutgeerts, et al.

Alimentary Pharmacology & Therapeutics|February 28, 2004

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's diseaseE Louis, Z El Ghoul, S Vermeire, et al.

Revue Medicale De Bruxelles|February 15, 2003

[The medical gastroenterology department]J Devière, M Adler, N Bourgeois, et al.

Acta Gastro-Enterologica Belgica|August 30, 2024

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infectionA Hoyois, C Gulkilik, L Mekkaoui, et al.

American Journal of Medical Genetics|August 15, 1994

Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.DJ P Hugot, P Laurent-Puig, C Gower-Rousseau, et al.

Acta Gastro-Enterologica Belgica|July 15, 2005

Report on the Belgian consensus meeting on colorectal cancer screeningM Adler, M De Vos, A Dufour, et al.

Clinical Nutrition (Edinburgh, Scotland)|June 16, 2001

Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre surveyA Van Gossum, K Vahedi, Abdel-Malik, et al.

Alimentary Pharmacology & Therapeutics|September 9, 2004

Rapid improvement of bone metabolism after infliximab treatment in Crohn's diseaseN Franchimont, V Putzeys, J Collette, et al.

Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:

Pageof 13

Clinical Nutrition (Edinburgh, Scotland)|April 1, 1996

Home parenteral nutrition in adults: a multicentre survey in Europe in 1993, A Van Gossum, H Bakker, et al.

Gut|June 15, 2004

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisD Franchimont, S Vermeire, H El Housni, et al.

Scandinavian Journal of Gastroenterology|August 23, 2002

A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphismE Louis, S Vermeire, P Rutgeerts, et al.

Alimentary Pharmacology & Therapeutics|February 28, 2004

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's diseaseE Louis, Z El Ghoul, S Vermeire, et al.

Revue Medicale De Bruxelles|February 15, 2003

[The medical gastroenterology department]J Devière, M Adler, N Bourgeois, et al.

Acta Gastro-Enterologica Belgica|August 30, 2024

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infectionA Hoyois, C Gulkilik, L Mekkaoui, et al.

American Journal of Medical Genetics|August 15, 1994

Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.DJ P Hugot, P Laurent-Puig, C Gower-Rousseau, et al.

Acta Gastro-Enterologica Belgica|July 15, 2005

Report on the Belgian consensus meeting on colorectal cancer screeningM Adler, M De Vos, A Dufour, et al.

Clinical Nutrition (Edinburgh, Scotland)|June 16, 2001

Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre surveyA Van Gossum, K Vahedi, Abdel-Malik, et al.

Alimentary Pharmacology & Therapeutics|September 9, 2004

Rapid improvement of bone metabolism after infliximab treatment in Crohn's diseaseN Franchimont, V Putzeys, J Collette, et al.

Pageof 13